Among them, CDKN1A (cyclin dependent kinase inhibitor 1A) was significantly downregulated (log2(fold change) = -1.173) and found to be a validated target gene for 22 miRs with increased expression in vulvar melanoma. Here, CDKN1A is linked to vulvar melanoma.